post-menopausal obesity
New vs Wegovy A 15% Boost in Obesity Treatment
New vs Wegovy A 15% Boost in Obesity Treatment The new GLP-1 combination therapy delivers about 15% greater weight loss than Wegovy in post-menopausal women. The finding comes from a 12-month trial presented at the European Congress on Obesity, offering a clear option for seniors seeking prescription weight-loss solutions. Medical